---
$id: https://graph.org.ai/products/commodity/51162722
$type: Product
source: UNSPSC
code: "51162722"
title: "Moguisteine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moguisteine

**UNSPSC Code**: 51162722
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent with the molecular formula C16H21NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6Y556547YY, chemically known as 3-thiazolidinepropanoic acid, 2-((2-methoxyphenoxy)methyl)-beta-oxo-, ethyl ester, (+-)- but more generally known as moguisteine, which bears US NIH Compound Identifier 65935. European Medicines Agency schedules Moguisteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09038MIG. The term MOGUISTEINE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule moguisteine under HS 29341000 and SITC 51579. As of Q4 2014, MOGUISTEINE remains US FDA's Preferred Term for this commodity. Moguisteine bears US NLM identifiers UMLS ID C0256172 and NCI Concept Code C66178. SMILES: S1C(N(CC1)C(=O)CC(=O)OCC)COC1C(OC)CCCC1.

